Loading candles…
Bliss GVS Pharma Limited, incorporated in 1984, operates in the pharmaceutical industry specializing in the development, manufacturing, marketing, trading, and export of pharmaceutical formulations. The company's product range includes suppositories, pessaries, capsules, tablets, and syrups. With over 40 years of industrial expertise, Bliss GVS Pharma is vertically integrated, covering the entire value chain from research and development through to global distribution. It maintains a strong global presence, exporting to more than 60 countries including regions such as Sub-Saharan Africa and India. The company is notable as one of the world's largest manufacturers of suppositories and pessaries.
This page is a live market overview for BLISS GVS PHARMA LTD (BLISSGVS) on the NSE. As a listed security, BLISS GVS PHARMA LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BLISSGVS before placing trades on tick2trade.
As of the latest feed, BLISSGVS last traded at ₹698.9 on NSE, up ₹4.3 (0.62%) from the previous close of ₹694.6. Today's session range is ₹681.05 – ₹717, against a 52-week band of ₹118 – ₹728. Traded volume today stands at 1.52L shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for BLISSGVS in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BLISSGVS is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BLISS GVS PHARMA LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BLISSGVS. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BLISSGVS option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | Please find enclosed herewith intimation regarding pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosur… | 12 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | 12 May 2026 |
| Unaudited Results - FY25 | To consider and approve the Unaudited financial results for the period ended December 31, 2025 and the interim dividend, if any, for the financial year 2025-… | 10 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2025 | 6 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 29 Jul 2025 |
| Intimation | Intimation of Board Meeting to consider Issuance of Sweat Equity Shares. | 12 May 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 12 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.